National Institute on Aging (NIA) awards $21M grant to support key phase 2b study of EIP Pharma's neflamapimod in dementia with Lewy bodies
/PRNewswire/ -- EIP Pharma Inc., a clinical stage company focused on developing treatments for neurodegenerative diseases today announced that the National...
United States James Galvin John Alam Nature Communications University Of Miami National Institutes Of Health
Source: prnewswire.com